GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PolyPid Ltd (NAS:PYPD) » Definitions » Price-to-Free-Cash-Flow

PolyPid (PolyPid) Price-to-Free-Cash-Flow : N/A (As of Apr. 30, 2024)


View and export this data going back to 2020. Start your Free Trial

What is PolyPid Price-to-Free-Cash-Flow?

As of today (2024-04-30), PolyPid's share price is $4.7721. PolyPid's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Hence, PolyPid's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for PolyPid's Price-to-Free-Cash-Flow or its related term are showing as below:

PYPD's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.61
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

PolyPid's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 44.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 17.50% per year.

During the past 10 years, PolyPid's highest 3-Year average Free Cash Flow per Share Growth Rate was 44.40% per year. The lowest was -96.00% per year. And the median was -9.80% per year.


PolyPid Price-to-Free-Cash-Flow Historical Data

The historical data trend for PolyPid's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPid Price-to-Free-Cash-Flow Chart

PolyPid Annual Data
Trend Dec12 Dec13 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PolyPid Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PolyPid's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, PolyPid's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PolyPid's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PolyPid's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PolyPid's Price-to-Free-Cash-Flow falls into.



PolyPid Price-to-Free-Cash-Flow Calculation

PolyPid's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.7721/0
=N/A

PolyPid's Share Price of today is $4.7721.
PolyPid's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

PolyPid  (NAS:PYPD) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


PolyPid Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PolyPid's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


PolyPid (PolyPid) Business Description

Traded in Other Exchanges
N/A
Address
18 Hasivim Street, P.O Box 7126, Petach Tikva, ISR, 495376
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, and Bacyssio are trademarks of the company. The company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

PolyPid (PolyPid) Headlines

From GuruFocus